Journey Medical (DERM) Gross Margin (2020 - 2026)
Journey Medical's (DERM) quarterly Gross Margin came in at 60.94% in Q1 2026, down 260.0% YoY from 38.09% in Q1 2025, and down 7.89% on a QoQ basis from 66.17% in Q4 2025.
Journey Medical (DERM) Gross Margin (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Gross Margin data on file, last reported at 60.94% in Q1 2026.
- Quarterly Gross Margin fell 260.0% year-over-year to 60.94% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 65.09% (up 70.0% YoY) and the FY2025 annual result came in at 66.17%, up 404.0% from the prior year.
- Gross Margin declined to 60.94% in Q1 2026, from 66.17% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 85.27% in Q4 2023 to a low of 46.99% in Q1 2023.
- A 5-year average of 62.65% and a median of 61.45% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin surged 3374 bps — and 2024, when it plunged 2235 bps.
- Tracing DERM's Gross Margin over 5 years: stood at 51.52% in 2022, then soared by 65 bps to 85.27% in 2023, then decreased by 26 bps to 62.92% in 2024, then gained by 5 bps to 66.17% in 2025, then retreated by 8 bps to 60.94% in 2026.
- The last three Gross Margin figures came in at 60.94% (Q1 2026), 66.17% (Q4 2025), and 66.2% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Journey Medical | 205.38 Mn | 179.73 Mn | 12.37 Mn | 66.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.81% |
| Mar 31, 2026 | 60.94% |
| Dec 31, 2025 | 66.17% |
| Sep 30, 2025 | 66.20% |
| Jun 30, 2025 | 67.09% |
| Mar 31, 2025 | 63.54% |
| Dec 31, 2024 | 62.92% |
| Sep 30, 2024 | 69.44% |
| Jun 30, 2024 | 61.45% |
| Mar 31, 2024 | 53.94% |
| Dec 31, 2023 | 85.27% |
| Sep 30, 2023 | 81.39% |
| Jun 30, 2023 | 54.21% |
| Mar 31, 2023 | 46.99% |
| Dec 31, 2022 | 51.52% |
| Sep 30, 2022 | 55.19% |
| Jun 30, 2022 | 58.27% |
| Mar 31, 2022 | 60.55% |
| Dec 31, 2021 | 45.62% |
| Sep 30, 2021 | 43.05% |